L364-0108 Screening compound: 4-(5-{[(3-chloro-4-methoxyphenyl)sulfonyl]amino}-1-methyl-1H-1,3-benzimidazol-2-yl)-N~1~-methylbenzamide

L364-0108 Screening compound: 4-(5-{[(3-chloro-4-methoxyphenyl)sulfonyl]amino}-1-methyl-1H-1,3-benzimidazol-2-yl)-N~1~-methylbenzamide
L364-0108 Screening compound: 4-(5-{[(3-chloro-4-methoxyphenyl)sulfonyl]amino}-1-methyl-1H-1,3-benzimidazol-2-yl)-N~1~-methylbenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L364-0108
4-(5-{[(3-chloro-4-methoxyphenyl)sulfonyl]amino}-1-methyl-1H-1,3-benzimidazol-2-yl)-N~1~-methylbenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L364-0108

Molecular Formula

C23H21ClN4O4S (C23 H21 ClN4 O4 S)

Compound Name

4-(5-{[(3-chloro-4-methoxyphenyl)sulfonyl]amino}-1-methyl-1H-1,3-benzimidazol-2-yl)-N~1~-methylbenzamide

IUPAC name

n/a

SMILES

CNC(c(cc1)ccc1-c1nc(cc(cc2)NS(c(cc3)cc(Cl)c3OC)(=O)=O)c2n1C)=O

InChI

InChI=1S/C23H21ClN4O4S/c1-25-23(29)15-6-4-14(5-7-15)22-26-19-12-16(8-10-20(19)28(22)2)27-33(30,31)17-9-11-21(32-3)18(24)13-17/h4-13,27H,1-3H3,(H,25,29)

InChI Key

OQVVDRYAHYCGPX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27247843

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

484.96

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.705

Distribution Coefficient, logD

3.698

Water Solubility, LogSw

-4.28

Polar Surface Area

84.092

Acid Dissociation Constant (pKa)

9.50

Base Dissociation Constant (pKb)

5.29

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

13.00

L364-0108 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Antimitotic Tubulin Library (17355 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin

References: we are preparing a list of scientific research reports with L364-0108 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L364-0108?
Check Price and Availability of L364-0108, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L364-0108 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L364-0108
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L364-0108
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L364-0108 available by request